Baxter International Inc (NYSE:BAX)
| 41.34 Delayed Data As of Jun 02 |  +0.105 / +0.25%Today’s Change | 37.35 Today|||52-Week Range 74.50 | -18.90% Year-to-Date |
BAX Regular Dividend: BAX began trading ex-dividend on 06/01/23. A $0.29 dividend will be paid to shareholders of record as of 06/02/23.
Latest BAX News | Press Releases
No recent news for Baxter International Inc.
Today’s Trading
| Previous close | 41.23 |
| Today’s open | 41.64 |
| Day’s range | 40.83 - 41.64 |
| Volume | 3,666,305 |
| Average volume (3 months) | 6,045,405 |
| Market cap | $20.9B |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -288.73% |
| Earnings growth (this year) | -16.28% |
| Earnings growth (next 5 years) | +1.30% |
| Revenue growth (last year) | +18.22% |
| P/E ratio | NM |
| Price/Sales | 1.70 |
| Price/Book | 3.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | +8.36 | +3.07% |
| SAUHFStraumann Holding AG | +0.70 | +0.46% |
| ---- | ||
| WSTWest Pharmaceutical ... | +2.14 | +0.63% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | July 27, 2023 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $15.1B |
| Annual profit (last year) | -$2.4B |
| Net profit margin | -16.10% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Deerfield, Illinois |
Forecasts
